TTM
$54.90M
YoY change
-3.3%
5Y CAGR
—
Peak year (2021)
−$12.06M
Cumulative operating income
−$241.17M
Operating Income history chart for Alto Neuroscience (ANRO) from 2021 to 2025
Latest: −$66.36M
Operating Income growth chart for Alto Neuroscience (ANRO) from 2021 to 2025
Latest: -3.3%
Operating Income history table for Alto Neuroscience (ANRO) from 2021 to 2025
| 2025 | −$66.36M | -3.3% | +$2.25M | ||
| 2024 | −$68.61M | +81.5% | −$30.80M | ||
| 2023 | −$37.81M | +29.5% | −$8.62M | ||
| 2022 | −$29.19M | +142.1% | −$17.14M | ||
| 2021 | −$12.06M | — | — |
- 2025−$66.36M-3.3%
- 2024−$68.61M+81.5%
- 2023−$37.81M+29.5%
- 2022−$29.19M+142.1%
- 2021−$12.06M—
Operating Income values are taken from Alto Neuroscience's reported income statements (quarterly 10-Q and annual 10-K filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the filing date. YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
About Operating Income at Alto Neuroscience (ANRO)
According to Alto Neuroscience's latest reported financial statements, the company's current operating income (TTM) is $54.90M. Operating income is profit from core operations: revenue minus cost of goods sold and operating expenses (SG&A, R&D). It excludes interest, taxes, and non-operating items, so it isolates how profitable the business itself is before financing and tax decisions. Compare with EBITDA and net income.
Headline TTM above sums the four reported quarters through (reported ). Chart and table below cover the full reported history back to .
As of the 2025 fiscal year, Alto Neuroscience (ANRO) reported operating income of −$66.36M – edged down 3.3% year-over-year.
The record annual operating income stands at −$12.06M, reached in 2021; the historical low of −$68.61M was recorded in 2024.
Alto Neuroscience Operating Income by Year
Alto Neuroscience Operating Income 2025: −$66.36M
In 2025, Alto Neuroscience reported operating income of −$66.36M, edged down 3.3% below 2024.
Alto Neuroscience Operating Income 2024: −$68.61M
Alto Neuroscience operating income in 2024 was −$68.61M, surged 81.5% from 2023. This figure represents the lowest annual value in the available history.
Alto Neuroscience Operating Income 2023: −$37.81M
2023's operating income for Alto Neuroscience came in at −$37.81M, grew 29.5% from 2022.
Alto Neuroscience Operating Income 2022: −$29.19M
Alto Neuroscience posted operating income of −$29.19M in 2022, surged 142.1% from 2021.
Alto Neuroscience Operating Income 2021: −$12.06M
Alto Neuroscience operating income in 2021 was −$12.06M.
See more financial history for Alto Neuroscience (ANRO).
Sector peers by Operating Income
Healthcare peers of Alto Neuroscience (ANRO), ranked by their latest operating income
| $29.70B | |
| $25.60B | |
| $23.49B | |
| $20.09B | |
| $19.90B | |
| $18.96B | |
| $13.74B | |
| $10.68B |
- $29.70B
- $25.60B
- $23.49B
- $20.09B
- $19.90B
- $18.96B
- $13.74B
- $10.68B
Frequently asked questions
Alto Neuroscience (ANRO) Key Financials
Charts, filings, and peer comparison for every metric
Explore more
Deep-dives across the income statement, cash flow, capital return, and valuation